6 companies in ARCH Venture Partners's investment portfolio.
Back to ARCH Venture Partners profile“Invests at concept stage, co-founding breakthrough life sciences and technology platforms with transformative potential.”
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
Lyft, Inc. is an American company offering ride-hailing services, motorized scooters, and bicycle-sharing systems in the United States and Canada, and, via its Free Now mobile app, Europe.
Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Leading robotic process automation (RPA) platform that helps organizations automate repetitive business processes.
Biotechnology company developing therapeutics to halt, slow, or reverse diseases of aging by targeting senescent cells.
ARCH Venture Partners has built a portfolio of 6 companies across 3 sectors, including Biotech, Consumer, Enterprise.
The portfolio reflects investments across the IPO stage, showing ARCH Venture Partners's approach to supporting companies at a focused stage of development.
ARCH Venture Partners has invested in 6+ companies across 3 different sectors.
ARCH Venture Partners's portfolio spans Biotech, Consumer, Enterprise. This diversification reflects the firm's broad investment thesis and sector expertise.
ARCH Venture Partners invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.